Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Deepak Nitrite Ltd

DEEPAKNTR
NSE
1,724.10
2.47%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Alert
Watchlist
Note

Deepak Nitrite Ltd

DEEPAKNTR
NSE
1,724.10
2.47%
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
23,516Cr
Close
Close Price
1,724.10
Industry
Industry
Chemicals - Inorganic
PE
Price To Earnings
44.09
PS
Price To Sales
2.96
Revenue
Revenue
7,946Cr
Rev Gr TTM
Revenue Growth TTM
-3.43%
PAT Gr TTM
PAT Growth TTM
-28.77%
Peer Comparison
How does DEEPAKNTR stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
DEEPAKNTR
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
1,9611,7681,7782,0092,1262,1672,0321,9032,1801,8901,9021,975
Growth YoY
Revenue Growth YoY%
4.8-14.1-9.40.98.422.514.3-5.32.5-12.8-6.43.8
Expenses
ExpensesCr
1,6131,5591,4761,7051,8251,8581,7341,7351,8631,7001,6981,764
Operating Profit
Operating ProfitCr
348210302305301309298169317190204211
OPM
OPM%
17.711.917.015.214.214.314.68.814.510.010.710.7
Other Income
Other IncomeCr
1332171499192121232520-4
Interest Expense
Interest ExpenseCr
4233466698811
Depreciation
DepreciationCr
413839424647484851515358
PBT
PBTCr
315202277274349275264135279155163138
Tax
TaxCr
815272729572703776424438
PAT
PATCr
23415020520225420319498203112119100
Growth YoY
PAT Growth YoY%
-12.5-36.117.5-3.48.635.1-5.3-51.4-20.2-44.6-38.91.7
NPM
NPM%
11.98.511.510.111.99.39.65.29.35.96.25.0
EPS
EPS
17.111.015.014.818.614.814.27.214.88.28.77.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
1,3271,3731,3711,6512,7004,2304,3606,8027,9727,6828,2827,946
Growth
Revenue Growth%
3.5-0.220.563.556.73.156.017.2-3.67.8-4.0
Expenses
ExpensesCr
1,1881,2061,2351,4552,2863,2043,1135,1996,6836,5597,1907,025
Operating Profit
Operating ProfitCr
1391671351964141,0261,2471,6041,2891,1231,092921
OPM
OPM%
10.512.29.911.915.324.328.623.616.214.613.211.6
Other Income
Other IncomeCr
22811215352243481568463
Interest Expense
Interest ExpenseCr
3840344583115743425122836
Depreciation
DepreciationCr
3640485378140153178166166195213
PBT
PBTCr
67891351112688061,0421,4341,1461,102953734
Tax
TaxCr
1426383294195266368294291255201
PAT
PATCr
536396791746117761,067852811697533
Growth
PAT Growth%
18.753.1-18.0119.8251.827.037.5-20.1-4.8-14.0-23.5
NPM
NPM%
4.04.67.04.86.414.417.815.710.710.68.46.7
EPS
EPS
5.15.88.26.012.744.856.978.262.559.551.139.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
212326272727272727272727
Reserves
ReservesCr
3254506898951,0441,5452,3193,3114,0634,7695,3615,488
Current Liabilities
Current LiabilitiesCr
4845988071,048884749553747794785923887
Non Current Liabilities
Non Current LiabilitiesCr
2932232656219738886603452454881,3701,446
Total Liabilities
Total LiabilitiesCr
1,1231,2941,7872,5912,9283,2093,5604,4305,1296,0967,7187,884
Current Assets
Current AssetsCr
4735817519931,1621,1561,4522,2852,7392,8423,2972,801
Non Current Assets
Non Current AssetsCr
6507131,0371,5981,7662,0522,1082,1462,3903,2554,4215,082
Total Assets
Total AssetsCr
1,1231,2941,7872,5912,9283,2093,5604,4305,1296,0967,7187,884

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
10816749183607651,002824650874625
Investing Cash Flow
Investing Cash FlowCr
-89-169-353-525-163-428-396-424-276-718-1,491
Financing Cash Flow
Financing Cash FlowCr
-22430534596-338-599-386-35944806
Net Cash Flow
Net Cash FlowCr
-3214-6-171415200-60
Free Cash Flow
Free Cash FlowCr
1881-192-438-181368790638293139-480
CFO To PAT
CFO To PAT%
203.8265.950.9231.634.7125.1129.177.276.3107.889.6
CFO To EBITDA
CFO To EBITDA%
77.6100.336.293.214.674.580.351.450.477.857.2

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7107881,7163,3943,7455,27322,60030,60925,12828,93827,043
Price To Earnings
Price To Earnings
14.013.217.843.021.68.629.128.729.535.738.8
Price To Sales
Price To Sales
0.50.61.32.11.41.35.24.53.13.83.3
Price To Book
Price To Book
2.11.72.43.73.53.49.69.26.16.05.0
EV To EBITDA
EV To EBITDA
8.47.316.921.511.76.118.619.319.525.625.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.039.938.337.139.043.948.139.532.931.830.1
OPM
OPM%
10.512.29.911.915.324.328.623.616.214.613.2
NPM
NPM%
4.04.67.04.86.414.417.815.710.710.68.4
ROCE
ROCE%
12.914.312.98.716.035.238.040.228.121.914.7
ROE
ROE%
15.313.313.58.616.238.933.131.920.816.912.9
ROA
ROA%
4.74.95.43.05.919.021.824.116.613.39.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Company Overview** **Deepak Nitrite Limited (DNL)** is a leading Indian manufacturer of chemical intermediates with over five decades of industry presence. Headquartered in Vadodara, Gujarat, DNL operates through a fully integrated model across the chemical value chain—from core chemical processes like nitration and hydrogenation to high-value specialty and performance chemicals. The company serves over 1,500 customers in more than **50 countries** across six continents, positioning itself as a “Supplier of Choice” for global pharmaceutical, agrochemical, and industrial clients. DNL’s product portfolio is organized into two primary reportable segments under Ind AS: 1. **Advanced Intermediates** 2. **Phenolics** It manufactures over **34 premium chemical intermediates** across **56+ applications**, including sodium nitrite, phenol, acetone, IPA, xylidines, oximes, toluidines, and optical brightening agents (OBA). The company operates **seven state-of-the-art manufacturing plants** in five strategic Indian locations: Nandesari, Dahej, and Sankarda (Gujarat); Taloja and Roha (Maharashtra); and Hyderabad (Telangana), with two additional sites under development. With a strong focus on **import substitution**, **Atmanirbhar Bharat**, and the **‘Make in India, Make for the World’** initiative, DNL aims to reduce India’s dependency on imported chemicals and emerge as a global hub for specialty chemicals. --- ### **Key Strategic Initiatives (as of Oct 2025)** #### **1. Inauguration of DRDC 2.0 – Next-Gen R&D Center (October 2025)** - DNL inaugurated **DRDC 2.0** in Savli, Vadodara, a **5-acre greenfield R&D campus** featuring cutting-edge laboratories, pilot plants, and AI-driven research tools. - The center, built at a cost of **over ₹100 crores**, aims to: - Accelerate innovation in **sustainable chemistry**, **green processes**, and **high-performance materials**. - Expand in-house R&D capabilities with **100+ professionals**, including multiple PhDs. - Drive product innovation in **pharmaceuticals**, **agrochemicals**, **advanced intermediates**, and **material sciences**. - The facility is intended to transform DNL into a **knowledge-driven chemical enterprise**, reducing time-to-market for new products. #### **2. Fully Integrated Polycarbonate (PC) Project – India’s First (Timeline: Dec 2027)** - Through its wholly-owned subsidiary **Deepak Chem Tech Limited (DCTL)**, DNL is building **India’s first integrated polycarbonate (PC) resin plant** at Dahej, Gujarat, with an annual capacity of **165,000 metric tonnes**. - The project includes: - Relocation and re-commissioning of **formerly Trinseo assets** from Stade, Germany. - Licensing of **CALIBRE™**, Trinseo’s trademark and proprietary technology. - Secured **15-year propylene supply agreement** with Petronet LNG (250,000 MTPA). - Applications: EV battery casings, medical devices, aerospace, defense, electronics, electronics, construction, and drones. - **Market Impact**: India currently imports ~400,000 MTPA of PC resins. This project will address over 40% of domestic demand upon full operation. #### **3. Vertical Integration Across the Phenolics Chain (₹8,500 Crore Investment)** - DNL is building **fully backward- and forward-integrated production capabilities** across the phenol–acetone–BPA–PC value chain: - **Greenfield Phenol–Acetone–IPA Complex** (Savli): 300 KTA Phenol, 185 KTA Acetone, 100 KTA IPA. - **MIBK and MIBC Solvent Plants**: Convert acetone into high-margin solvents for pharmaceuticals, electronics, and coatings. - **White Nitric Acid (WNA) and Concentrated Nitric Acid (CNA) Plants**: Strengthen upstream integration for nitrated products. - This integration will allow **over 50% of base chemical output** to be converted into **high-value derivatives**, enhancing margins and EBITDA. #### **4. Expansion into Specialty Polymers and High-Growth Platforms** - **MMA/PMMA Resins**: India is 100% import-dependent. DNL plans to produce these transparent, high-durability polymers for automotive and electronics sectors. - **Aniline Production**: For high-grade aramid applications in defense, not standard PU-grade, ensuring premium margin products. - **Fluorination and Photochlorination Platforms**: To manufacture critical intermediates for agrochemicals, semiconductors, and precision agriculture. - DNL is also developing **first-of-its-kind processes**, including patented routes for high-carbon-footprint reduction via low-waste chemistry. #### **5. Sustainability and Decarbonization** - DNL has adopted a **60–70% renewable energy target by FY2027**, with: - **Commercial PPAs** in place since 2026. - Expected **eCO₂ reduction of 60–65%**. - **Cost savings** in energy due to renewable PPA. - Investments in **multifuel boilers**, **low-energy ETP**, **waste recovery**, and **byproduct valorization** (e.g., Acetophenone recovery from phenol waste stream). --- ### **Operational Highlights (Q2 FY2025–26)** #### **Capacity Commissioning Milestones:** | Project | Commissioning Status (Oct 2025) | |---------------------------|------------------------------------------------------| | **Hydrogenation Facility**| Trial production started, full ramp-up Q2 FY25–26 | | **WNA (White Nitric Acid)**| Trial commissioning; full capacity by Q2 FY25–26 | | **MIBK–MIBC Solvent Plant**| Final stage of commissioning; ramp-up to begin | | **Nitric Acid Plant** | Fully operational; benefits from Q3 FY25–26 onward | | **PC Compounding Plant** | Already operational since FY25; serving EV and medtech sectors | #### **Financial & Operational Impact:** - Nitric acid project to improve **EBITDA by 2–3%** and **Advanced Intermediates segment margin by 200–300 bps**. - MIBK/MIBC ramp expected to be **faster than 12 months** due to high customer interest (cosmetics, high-margin pharma). - **Advanced Process Controls (APC)** with AI-based real-time optimization rolled out across seven sites, making DNL **one of the few Indian chemical firms using large-scale APC**. --- ### **Subsidiaries Driving Transformation** 1. **Deepak Phenolics Limited (DPL)** - Market leader in India for **phenol, acetone, and IPA**. - Contributed **~69% of DNL’s revenue** in FY24–25. - Capacity: 300 KTA Phenol, 185 KTA Acetone, 60 KTA IPA. 2. **Deepak Chem Tech Limited (DCTL)** - Primary vehicle for DNL’s **specialty chemicals and polymer future**. - Executing **₹8,500 crore investment** in phenol–polycarbonate value chain. - Holds **CALIBRE™** brand and technology rights. - Signed binding term sheets with **Petronet LNG** and **Gujarat Government**. 3. **Deepak Oman Industries (DOIL)** - **51% owned subsidiary** producing **sodium nitrite/nitrate** in Oman using low-cost feedstock and energy. - Enhances competitiveness in export markets. --- ### **R&D and Innovation Ecosystem** - **Deepak Research & Development Centre (DRDC), Nandesari**: Government-recognized, with: - **77 patent applications filed (22 granted)** as of Oct 2025. - Focus: Sustainable processes, process intensification, and green technologies. - **Two Pilot Plants (Roha, Nandesari)**: Bridge lab R&D to commercial scale for agrochemicals, pharmaceuticals, and dyes. - **Digital Twin & tEG Platform**: Real-time supply chain optimization using AI, IoT, and cloud analytics. - **AI and Digitalization**: Deployed across procurement, logistics, manufacturing, and lab systems. --- ### **Strategic Differentiation** - **Vertical Integration:** Unique position from ammonia to amines to polycarbonates. - **Import Substitution Champion:** Already replaced imports of sodium nitrite, phenol, acetone, IPA; expanding to PC, MMA, BPA. - **Global Positioning:** ~77.5% of revenue from India (domestic resilience), only **2.5–3% from the U.S.**, minimizing tariff risks. - **China+1 Winner:** Indian manufacturing strength, skilled workforce, and sustainability edge make DNL an ideal supplier for global re-shoring. - **Backed by Policy:** Aligned with **Make in India**, **Atmanirbhar Bharat**, **PLI Schemes**, and Gujarat’s PCPIR ecosystem.